Eli Lilly is looking to approach regulatory approval of efsitora alfa (efsitora), its once-weekly insulin for type 2 diabetes ...

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

Australia: A recent multicentre audit conducted in Queensland, Australia, has provided compelling real-world evidence ...

The endocrinologist and researcher was one of several investigators who presented Phase 3 clinical trial results at the 85th Scientific Sessions of the American Diabetes Association for a long-lasting ...

A new study published in the Journal of Ultrasound in Medicine ultrasound of one's thigh or shoulder muscle can help detect ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

In the face of a housing and construction labor crisis, some people are choosing energy efficient homes that are ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

A common blood test can flag early Alzheimer's disease patients who are four times more likely to experience rapid brain ...

Good morning! Today, we get deeper into the ousting of Nicole Verdun at the FDA, see promise from Vertex’s cell therapy for ...

MannKind Corporation (NASDAQ:MNKD) aims to release the topline results from the full pediatric study with safety extension in ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...